Clinical trials in Moldova
153 studies list at least one site in Moldova. 60 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the studies in Moldova recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Most studied here
Who runs them
Janssen Research & Development, LLC (6) · Vir Biotechnology, Inc. (5) · AstraZeneca (5) · Sanofi (5) · Gilead Sciences (4) · Celgene (4) · Regeneron Pharmaceuticals (4) · Otsuka Pharmaceutical Development & Commercialization, Inc. (3)
What changed recently
From the registry's own updates since Oct 11, 2026.
First site in Moldova3
- To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of TreatmentOct 28, 2026NCT07684820
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisOct 16, 2026NCT07185009
- Study of ARO-DIMERPA in Adult Participants With Mixed HyperlipidemiaOct 13, 2026NCT07223658
Newly registered1
Studies
Recruiting first, then most recently updated. Showing 50 of 153 — search for more.
- A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast CancerRecruitingNCT06827236Phase 1/2
- DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard ChemoimmunotherapyRecruitingNCT07472517Phase 3
- Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBDEnrolling by invitationNCT07652294Phase 2
- A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDPRecruitingNCT07091630Phase 3
- Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With MelanomaRecruitingNCT07476326Phase 1
- REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult ParticipantsRecruitingNCT07213778Phase 3
- A Rollover Study for Continued Study Treatment and Ongoing Safety MonitoringEnrolling by invitationNCT06788509Phase 1
- A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's DiseaseRecruitingNCT06226883Phase 2
- A Study of LY3971297 in Participants With Heart FailureRecruitingNCT07547540Phase 1
- A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)RecruitingNCT07363590Phase 1
- Study of XmAb942 in Healthy Participants and Participants With Ulcerative ColitisRecruitingNCT06619990Phase 1/2
- A Platform Study in Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT06996782Phase 1/2
- To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of TreatmentRecruitingNCT07684820Phase 2
- A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative ColitisRecruitingNCT07012395Phase 2
- A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus ErythematosusRecruitingNCT06613360Phase 1
- A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or ObesityRecruitingNCT06842186Phase 1/2
- A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary TuberculosisRecruitingNCT07209761Phase 3
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisRecruitingNCT07184996Phase 3
- A Phase 1 Study of JADE201 in Participants With Rheumatoid ArthritisRecruitingNCT07533955Phase 1
- A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)RecruitingNCT07111520Phase 1/2
- Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaNot yet recruitingNCT07885891Phase 3
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRecruitingNCT07184944Phase 3
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRecruitingNCT07184931Phase 3
- Confirmatory Clinical Study in Active Ulcerative ColitisRecruitingNCT07296315Phase 2
- An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid TumorsRecruitingNCT06589596Phase 1
- A Study of MB-001 in Moderately to Severely Active Ulcerative ColitisRecruitingNCT07374471Phase 1/2
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisRecruitingNCT07185009Phase 3
- Platform Assessing Regimens and Durations In a Global Multisite Consortium for TBRecruitingNCT06114628Phase 2
- BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid TumorsRecruitingNCT06120283Phase 1
- Study of ARO-DIMERPA in Adult Participants With Mixed HyperlipidemiaRecruitingNCT07223658Phase 1/2
- A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell MalignanciesRecruitingNCT05006716Phase 1/2
- AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2RecruitingNCT06219941Phase 2
- Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid ArthritisRecruitingNCT07207954Phase 1
- A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis BRecruitingNCT07389044Phase 1
- Bioneer Q-RFIA Clinical EvaluationRecruitingNCT05117788
- A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal CancerRecruitingNCT07693751Phase 1/2
- PRIDE III Prison Interventions and HIV Prevention CollaborationRecruitingNCT06962033Not applicable
- A Study to Assess Safety and Efficacy of SOT106 in Patients With LRRC15-positive Advanced Unresectable or Metastatic Osteosarcoma or Soft Tissue SarcomaNot yet recruitingNCT07801222Phase 1/2
- Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta VirusRecruitingNCT07096193Phase 1/2
- Validation of Sudden Cardiac Arrest Risk Factors in Patients With CADRecruitingNCT07444931
- Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis BRecruitingNCT06680232Phase 1
- A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus InfectionNot yet recruitingNCT07762027Phase 2
- Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell MalignanciesRecruitingNCT06980116Phase 1
- A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative ColitisNot yet recruitingNCT07760831Phase 1
- A Phase 1b Open-label Study to Evaluate Safety of Plamotamab in Participants With Rheumatoid ArthritisRecruitingNCT07230353Phase 1
- VIPPSTAR-G1 Digital Early Intervention for Visual ImpairmentNot yet recruitingNCT07717671Not applicable
- A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult PatientsRecruitingNCT07472491Phase 2/3
- Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin DeficiencyEnrolling by invitationNCT02796937Phase 3
- Randomized Controlled Trial of a Family-focused Intervention for Caregivers and Young Adolescents (Phase 3 of FLOURISH)RecruitingNCT07240571Not applicable
- A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell CancersRecruitingNCT05910827Phase 1/2